Metraipolis › archive › dc_cd33994f8bfe

Family health history and pharmacogenomics show cross generation premature amitriptyline discontinuation is associated with CYP2C19 loss of-function enrichment — Europe PMC PMID:41233583

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41233583
DOI
10.1038/s43856-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-08T14:30:30.300Z
SHA-256 of the archived text
e013b08d3a9cad52886413798b75cec7d439839a1c9b1554eced09d2286a9c79
Stable URL of this page
https://metraipolis.com/documento/dc_cd33994f8bfe

How to cite

Family health history and pharmacogenomics show cross generation premature amitriptyline discontinuation is associated with CYP2C19 loss of-function enrichment — Europe PMC PMID:41233583 — Europe PMC (en), https://europepmc.org/article/MED/41233583 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd33994f8bfe (Metraipolis archive dc_cd33994f8bfe, sha256 e013b08d3a9cad52886413798b75cec7d439839a1c9b1554eced09d2286a9c79)
BibTeX
@misc{dccd33994f8bfe,
  title = {Family health history and pharmacogenomics show cross generation premature amitriptyline discontinuation is associated with CYP2C19 loss of-function enrichment — Europe PMC PMID:41233583},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41233583},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd33994f8bfe; sha256 e013b08d3a9cad52886413798b75cec7d439839a1c9b1554eced09d2286a9c79},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41233583. Agents can read the archived copy with the MCP tool read_document.